Metropolitan Bank (MCB) Insider Sale: 3,000 Shares Disclosed
Rhea-AI Filing Summary
Metropolitan Bank Holding Corp. insider report: Director Dale C. Fredston sold a total of 3,000 shares of the issuer on 09/03/2025 in two sets of transactions. The larger block of 2,841 shares was sold at a weighted-average price of $78.6167 (individual prices ranged $78.05–$79.042). A second block of 159 shares was sold at a weighted-average price of $79.2727 (prices ranged $79.107–$79.36). After these sales the reported beneficial ownership is shown as 14,168 shares (with a prior line showing 14,327 that includes restricted stock units). The filing discloses that restricted stock units vesting 100% on January 27, 2026 are included in the beneficial ownership figure.
Positive
- Disclosure transparency: filing provides weighted-average prices and explicit price ranges for the multiple transactions
- Ongoing ownership: reporting person retains approximately 14,168 beneficially owned shares and includes RSUs vesting 100% on January 27, 2026
Negative
- Insider sales: Director sold a total of 3,000 shares on 09/03/2025 at weighted-average prices of $78.6167 and $79.2727, which may be perceived negatively by some investors
- No 10b5-1 disclosure: the form does not indicate the transactions were made pursuant to a prearranged 10b5-1 trading plan
Insights
TL;DR: Insider sold 3,000 shares across multiple trades at ~ $78.62–$79.27, leaving ~14.2k shares including RSUs.
The transactions are routine insider sales rather than option exercises or derivative activity. The sale size (3,000 shares) should be evaluated against total outstanding shares to judge materiality; the filing does not state total shares outstanding so material impact on market capitalization cannot be determined from this Form 4 alone. The disclosure of weighted-average prices and price ranges is helpful for transparency. The inclusion of restricted stock units vesting in January 2026 signals ongoing alignment with equity-based compensation.
TL;DR: Director sales were properly disclosed; retained holdings plus RSUs indicate continued stake and alignment.
The Form 4 shows timely reporting and detailed footnotes describing weighted-average pricing and vesting schedules, which satisfies Section 16 disclosure norms. The director remains a holder of roughly 14.2k shares including RSUs that vest in January 2026, indicating ongoing economic exposure. There is no indication of trading pursuant to a 10b5-1 plan in the filing, and no derivatives or other arrangements are reported.